📰 Clinical Modification News
Page 4 - Clinical Modification News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Modification. Real-time updates on events, politics, business and more.
August 9, 2023
Study authors used data from the Taiwan National Healthcare Insurance Research database and Death Registry for their population-based retrospective cohort study.
August 3, 2023
Obesity is associated with poor outcomes, increased mortality, and increased rates of mechanical ventilation among patients hospitalized with COVID-19.
August 1, 2023
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...
July 24, 2023
Author summary Why was this study done? There have been an increasing number of cases of type 1 diabetes reported following Coronavirus Disease 2019 (COVID-19) vaccinations. The relationship between receiving COVID-19 vaccines and incident diabetes has not been examined in population-based studies. Several nationwide cohorts reported higher risks of incident diabetes following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The risk of incident diabetes following infect...
July 19, 2023
This new data on factors which may inhibit access to dermatologic care indicates the potential value for policy-makers as well as educators to make changes to fill such gaps in care.
July 18, 2023
This article explores the patient-sharing relationships between acute hospitals and postacute hospitals and how these relationships influence patient discharge outcomes.
July 12, 2023
Investigators urge policymakers to establish flexible models that maximize coverage when respiratory syncytial virus activity is high and minimize unnecessary doses when viral activity is low.
July 6, 2023
Allopurinol, an approved drug for gout, may be repurposed to help reduce the risk for neurodegenerative diseases, such as PD, AD, and ALS.
June 27, 2023
Allopurinol, an approved drug for gout, may be repurposed to help reduce the risk for neurodegenerative diseases, such as PD, AD, and ALS.